Antibodies directed to Tumor Necrosis Factor and uses thereof

Details for Australian Patent Application No. 2003298816 (hide)

International Classifications

Event Publications

6 May 2004 Complete Application Filed

Priority application(s): 60/430,729 02.12.02 US

29 July 2004 Application Open to Public Inspection

Published as AU-B-2003298816

19 January 2006 Amendment Made

The nature of the amendment is: Amend co-inventor name from Qiaojuan, Jane Su to Su, Qiaojuan Jane 2004

8 January 2009 Alteration of Name

The name of the applicant has been altered to Amgen Fremont, Inc.

17 June 2010 Application Accepted

Published as AU-B-2003298816

26 August 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 12 Aug 2010. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

16 December 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 12 Aug 2010

23 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.